|
|
Exchange: |
American Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
106,883,000 |
Market
Cap: |
1.04(M) |
Last
Volume: |
9,926 |
Avg
Vol: |
79,104 |
52
Week Range: |
$0.009725 - $0.049 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile RegeneRX Biopharmaceuticals is a biopharmaceutical company focused on the development of a therapeutic peptide, Thymosin beta 4 (Tss4), for tissue and organ protection, repair, and regeneration. Co. has formulated Tss4 into three product candidates in clinical development: RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease or other pathology; RGN-352, an injectable formulation to treat cardiovascular diseases, central and peripheral nervous system diseases, and other medical indications that may be treated by systemic administration; and RGN-137, a topical gel for dermal wounds and reduction of scar tissue.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Goldstein Allan L |
Director |
|
2021-12-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
130,000 |
1,507,793 |
|
- |
|
Finkelstein J J |
President and CEO |
|
2021-06-30 |
4 |
B |
$0.20 |
$15,000 |
D/D |
75,000 |
1,712,991 |
2.81 |
-40% |
|
Goldstein Allan L |
Director |
|
2021-06-30 |
4 |
B |
$0.20 |
$25,000 |
D/D |
125,000 |
1,637,793 |
2.39 |
-40% |
|
Cavazza Paolo |
10% Owner |
|
2021-06-30 |
4 |
B |
$0.20 |
$300,000 |
I/I |
1,500,000 |
1,500,000 |
1.5 |
-40% |
|
Goldstein Allan L |
Director |
|
2019-06-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
228,000 |
1,712,793 |
|
- |
|
Goldstein Allan L |
Director |
|
2019-01-06 |
4 |
OE |
$0.06 |
$12,535 |
D/D |
208,912 |
1,940,793 |
|
- |
|
Mcnay Joseph C |
Director |
|
2019-01-06 |
4 |
OE |
$0.06 |
$31,337 |
D/D |
522,280 |
6,524,122 |
|
- |
|
Cavazza Preta Martina |
10% Owner |
|
2018-09-27 |
4 |
OE |
$0.06 |
$188,021 |
D/D |
3,133,681 |
34,989,080 |
|
- |
|
Elsey R Don |
Director |
|
2018-09-11 |
4 |
OE |
$0.06 |
$6,267 |
D/D |
104,456 |
104,456 |
|
- |
|
Mcnay Joseph C |
Director |
|
2018-09-11 |
4 |
OE |
$0.06 |
$125,347 |
D/D |
2,089,120 |
6,001,842 |
|
- |
|
Goldstein Allan L |
Director |
|
2018-09-11 |
4 |
OE |
$0.06 |
$13,788 |
D/D |
229,803 |
1,731,881 |
|
- |
|
Finkelstein J J |
President and CEO |
|
2018-07-05 |
4 |
OE |
$0.06 |
$6,267 |
D/D |
104,456 |
1,637,991 |
|
- |
|
Mcnay Joseph C |
Director |
|
2018-07-05 |
4 |
OE |
$0.06 |
$62,674 |
D/D |
1,044,560 |
3,912,722 |
|
- |
|
Goldstein Allan L |
Director |
|
2018-07-05 |
4 |
OE |
$0.06 |
$12,535 |
D/D |
208,912 |
1,502,078 |
|
- |
|
Mcnay Joseph C |
Director |
|
2018-03-29 |
4 |
OE |
$0.06 |
$62,674 |
D/D |
1,044,560 |
2,868,162 |
|
- |
|
Goldstein Allan L |
Director |
|
2018-03-29 |
4 |
OE |
$0.06 |
$31,337 |
D/D |
522,280 |
1,293,166 |
|
- |
|
Cavazza Preta Martina |
10% Owner |
|
2018-03-13 |
4 |
B |
$0.23 |
$4,124,745 |
D/D |
17,933,673 |
31,855,399 |
2.45 |
- |
|
Sinaf S.a. |
10% Owner |
|
2018-03-13 |
4 |
S |
$0.23 |
$2,664,503 |
D/D |
(11,584,795) |
0 |
|
- |
|
Goldstein Allan L |
Director |
|
2018-01-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
250,000 |
770,886 |
|
- |
|
Mcnay Joseph C |
Director |
|
2017-10-19 |
4 |
OE |
$0.15 |
$10,000 |
D/D |
66,667 |
1,823,602 |
|
- |
|
Mcnay Joseph C |
Director |
|
2017-10-19 |
4 |
OE |
$0.15 |
$62,674 |
D/D |
417,824 |
1,756,935 |
|
- |
|
Finkelstein J J |
President and CEO |
|
2017-10-19 |
4 |
OE |
$0.15 |
$3,000 |
D/D |
20,000 |
1,533,535 |
|
- |
|
Finkelstein J J |
President and CEO |
|
2017-10-19 |
4 |
OE |
$0.15 |
$18,802 |
D/D |
125,347 |
1,513,535 |
|
- |
|
Goldstein Allan L |
Director |
|
2017-10-19 |
4 |
OE |
$0.15 |
$7,000 |
D/D |
46,666 |
1,020,886 |
|
- |
|
Goldstein Allan L |
Director |
|
2017-10-19 |
4 |
OE |
$0.15 |
$43,872 |
D/D |
292,477 |
974,220 |
|
- |
|
37 Records found
|
|
Page 1 of 2 |
|
|